Tagged with Germany

Europe Drawing from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry, we present the Top 5 countries across a variety of pharma metrics: from market size to R&D spend, production, exports, imports, and generics penetration.   Made with Visme Infographic Maker   Made with…

Germany The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck KGaA; the CureVac vaccine’s role in fighting COVID-19 variants; and why the country is trailing its European neighbours in digital health.   Merck KGaA’s new CEO shakes up U.S. leadership to spark…

Germany A roundup of some of the most important recent news from German pharma, including state honours for the founders of BioNTech, the latest on vaccines and lockdowns in the country, as well as the German pharma firms making international investments and predicting mid-term growth.   Pharma companies must deliver promised…

Germany After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness to make bold bets on areas including consumer healthcare, medical cannabis, and research into public opinion on healthcare   STADA, based in Bad Vilbel, focuses on a two-pillar strategy consisting of generics, including specialty…

Singapore The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences within it. Dr Philippi also outlines the impact of the COVID-19 pandemic on the SGC’s members and why Singapore remains the premier investment destination for European companies in Asia.  …

Germany German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant Pfizer on a COVID-19 vaccine. The company, founded by Professor Ugur Sahin in 2008 with the goal of creating a wide portfolio of individualised treatments for cancer patients, is one of the leading…

Merck PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to unpack her important role within the global group and how Merck has pivoted to rise to the supply chain challenges posed by the COVID-19 crisis.   Although many companies now claim to have this…

Merck Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number of headline-grabbing investments in sites in its home market of Germany and across the world. Moreover, the company is now increasingly at the forefront of digitalisation and innovation in its manufacturing and…

Europe Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to innovative medicines and COVID-19 treatments.   The so-called “power couple” – German chancellor Angela Merkel and French president Emmanuel Macron –  presented a jointly developed five-point…

Germany Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big new investments from Merck and Bayer, the implications of the country’s new Digital Healthcare Act, the impact of the coronavirus outbreak on investor sentiment, and the health minister potentially poised to become Germany’s…

Pharma Legal Handbook Want to know more about cannabinoid drugs, medicinal cannabis and opioid drugs in Germany? Read on! Prepared in association with Heuking Kühn Lüer Wojtek, a leading global law firm, this is an extract from The Pharma Legal Handbook: Germany, available to purchase here for USD 99.   Cannabinoid Drugs 1.…

Czech Republic Bernard Bauer, CEO and board member at the German-Czech Chamber of Industry and Commerce, discusses the factors that make the German-Czech collaboration such a natural and powerful one, out of which the two countries’ common industrial tradition plays a key role. Furthermore, Bauer assesses the evolution of bilateral trade relations,…